
1. blood. 2015 jan 15;125(3):534-41. doi: 10.1182/blood-2014-04-567149. epub 2014
nov 20.

red cells ferrochelatase-deficient erythropoietic protoporphyria patients
are resistant growth malarial parasites.

smith cm(1), jerkovic a(2), puy h(3), winship i(4), deybach jc(5), gouya l(6),
van dooren g(7), goodman cd(8), sturm a(8), manceau h(5), mcfadden gi(8), david
p(9), mercereau-puijalon o(9), burgio g(2), mcmorran bj(2), foote sj(10).

author information: 
(1)menzies research institute tasmania school medicine, university of
tasmania, hobart, tas, australia;
(2)australian school advanced medicine, macquarie university, north ryde, nsw,
australia;
(3)centre français des porphyries, hôpital louis mourier, assistance
publique-hôpitaux de paris, colombes, france; centre de recherche sur
l'inflammation, inserm u1149, paris, france; groupe d'excellence, pôle de
recherche et d'enseignement supérieur, sorbonne paris-cité, paris, france;
(4)department medicine, university melbourne, melbourne, vic, australia;
office research, royal melbourne hospital, parkville, vic, australia;
(5)centre français des porphyries, hôpital louis mourier, assistance
publique-hôpitaux de paris, colombes, france; centre de recherche sur
l'inflammation, inserm u1149, paris, france;
(6)centre de recherche sur l'inflammation, inserm u1149, paris, france; groupe
d'excellence, pôle de recherche et d'enseignement supérieur, sorbonne paris-cité,
paris, france;
(7)research school biology, australian national university, canberra, act,
australia;
(8)school botany, university melbourne, parkville, vic, australia;
(9)institut pasteur, unité d'immunologie moléculaire des parasites, centre
nationale de la recherche scientifique, unite de recherche associé 2581, paris,
france; and.
(10)australian school advanced medicine, macquarie university, north ryde,
nsw, australia; john curtin school medical research, australian national
university, canberra, act, australia.

many red cell polymorphisms result selective pressure malarial
parasite. here, add another red cell disease panoply erythrocytic
changes give rise resistance malaria. erythrocytes individuals
with erythropoietic protoporphyria (epp) low levels final enzyme in
the heme biosynthetic pathway, ferrochelatase. cells patients are
resistant growth plasmodium falciparum malarial parasites. this
phenomenon due absence ferrochelatase accumulation of
substrate, demonstrated normal growth p falciparum parasites 
epp phenocopy, x-linked dominant protoporphyria, elevated substrate,
and normal ferrochelatase levels. observation replicated mouse
strain hypomorphic mutation murine ferrochelatase gene. the
parasite enzyme essential parasite growth plasmodium berghei
parasites carrying complete deletion ferrochelatase gene grow normally
in erythrocytes, confirms previous studies. ferrochelatase is
essential parasite growth confirmed showing inhibition of
ferrochelatase using specific competitive inhibitor, n-methylprotoporphyrin, 
produced potent growth inhibition effect cultures p falciparum. this
raises possibility targeting human ferrochelatase host-directed
antimalarial strategy.

© 2015 american society hematology.

doi: 10.1182/blood-2014-04-567149 
pmcid: pmc4296013
pmid: 25414439  [indexed medline]

